Memory loss during lenalidomide treatment: a report on two cases

BACKGROUND: There are many reports of cognitive dysfunction in patients receiving chemotherapy or targeted therapies. Many antineoplastic agents may be involved in the condition also known as “chemo brain” or “chemo fog”. CASE PRESENTATION: Two male patients (aged 41 and 70) with multiple myeloma de...

Descripción completa

Detalles Bibliográficos
Autores principales: Rollin-Sillaire, Adeline, Delbeuck, Xavier, Pollet, Marianne, Mackowiak, Marie-Anne, Lenfant, Pierre, Noel, Marie-Pierre, Facon, Thierry, Leleu, Xavier, Pasquier, Florence, Le Rhun, Emilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751879/
https://www.ncbi.nlm.nih.gov/pubmed/23937917
http://dx.doi.org/10.1186/2050-6511-14-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751879/
https://www.ncbi.nlm.nih.gov/pubmed/23937917
http://dx.doi.org/10.1186/2050-6511-14-41

Ejemplares similares